Insight Guide
What’s Next for mRNA?
![What’s Next for mRNA?](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/pharmaceutical-science/outsourcing-pharma.com/resources/data-management/what-s-next-for-mrna/13186262-1-eng-GB/What-s-Next-for-mRNA.jpg)
Now that the pharma industry and regulators have significant data on safety and efficacy of mRNA vaccines, many companies are looking beyond infectious disease to potentially develop therapies for a variety of indications. In this Q&A, a Catalent Biologics expert addresses the challenges of mRNA development and manufacturing, potential solutions & the future of mRNA in industry.